Tech Company Financing Transactions
Abridge Funding Round
Abridge closed a $250 million Series D financing round on 2/17/2025. Backers included Elad Gil, IVP and Bessemer Venture Partners.
Transaction Overview
Company Name
Announced On
2/17/2025
Transaction Type
Venture Equity
Amount
$250,000,000
Round
Series D
Investors
Proceeds Purpose
The company intends to use the funds to further enhance additional development of AI capabilities and commercial growth to support broader applications.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
224 North Euclid Ave. 311
Pittsburgh, PA 15206
USA
Pittsburgh, PA 15206
USA
Phone
Undisclosed
Website
Email Address
Overview
Abridge was created for everyone, with a mission to help us all better understand our health conversations, whether at home or in the hospital. Abridge was inspired in part by my family's experience with a rare disease, and by the people I've cared for in clinic.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shiv Rao
Chief Scientific Officer
Florian Metze
Chief Technical Officer
Sandeep Konam
Browse more venture capital transactions:
Prev: 2/17/2025: Polymath venture capital transaction
Next: 2/17/2025: Flit venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs